← brief for 2026-10-06 · Slowing decline

GLP-1 Receptor Agonists Versus DPP-4 Inhibitors and Incident Dementia Risk in COVID-19 Survivors with Type 2 Diabetes: A Target Trial Emulation Study.

Key takeaways

This study compared two diabetes drugs in people who had COVID-19. It looked at the risk of developing dementia. This is an observational study, so it shows a link, not proof of cause.

Who did this work

Hung KC (Department of Anesthesiology, Chi Mei Medical Center, Tainan, Taiwan.) · Yu TS (Department of Anesthesiology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.) · Liu PH (Department of Anesthesiology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.) · Lai YC (Department of Anesthesiology, Chi Mei Medical Center, Tainan, Taiwan.) · Chen IW (Department of Anesthesiology, Chi Mei Hospital, Liouying, Tainan, Taiwan.)

Source

Article · Europe PMC, CKD · 2026-09-30
https://doi.org/10.2147/dddt.s638249